Dr. Andrew Zolopa M.D.

Publications

• Clinical infectious diseasesLow Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral2013
• JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESA Randomized Double-Blind Comparison of Coformulated2013
• AIDSTest performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS2013
• JOURL OF GENE MEDICINEPatient monitoring and follow-up in lentiviral clinical trials2013
• JOURL OF INFECTIOUS DISEASESElevated Interleukin 8 and T-Helper 1 and T2012
• Current HIV/AIDS reportsWhen to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!2012
• LANCETCo-formulated elvitegravir2012
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYStandardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase2012
• PLOS ONEAssociation of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults2011
• CLINICAL INFECTIOUS DISEASESBlood (1 -> 3)-beta-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia2011
• AIDSCost-effectiveness of antiretroviral regimens in the World Health Organization's treatment2011
• JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESInflammation and Mortality in HIV-Infected Adults: Alysis of the FRAM Study Cohort2010
• CLINICAL INFECTIOUS DISEASESConcerns Regarding a R2010
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYHIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance2010
• HIV CLINICAL TRIALSEarly Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections2010
• CURRENT OPINION IN INVESTIGATIOL DRUGSOptimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance2010
• PLOS ONERisk Factor Alyses for Immune Reconstitution Inflammatory Syndrome in a R2010
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYPredicting Tipravir and Daruvir Resistance Using Genotypic, Phenotypic2010
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIntertiol Cohort Alysis of the Antiviral Activities of Zidovudine2010
• JOURL OF INFECTIOUS DISEASESActivity of Elvitegravir, a Once-Daily Integrase Inhibitor2010
• AIDSDevelopment of a didanosene genotypic resistance interpretation system based on large derivation2010
• JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESAssociation of HIV Infection2010
• ANTIVIRAL RESEARCHThe evolution of HIV treatment guidelines: Current state-of-the-art of ART2010
• JOURL OF CLINICAL VIROLOGYSwitch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients2009
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYNonpolymorphic Human Immunodeficiency Virus Type 1 Protease2009
• CURRENT OPINION IN HIV AND AIDSThe use of resistance testing in the magement of HIV-1-infected patients2009
• PLOS ONEEarly Antiretroviral Therapy Reduces AIDS Progression2009
• Current HIV/AIDS reportsInitiation of antiretroviral therapy in the hospitalized patient with an acute AIDS2009
• CLINICAL INFECTIOUS DISEASESMaintaining Reduced Viral Fitness2009
• JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESHepatotoxicity and Gastrointestil Intolerance When Healthy Volunteers Taking Rifampin Add Twice2009
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYSafety and Efficacy of Enfuvirtide in Combition with Daruvir2008
• AMERICAN JOURL OF CLINICAL NUTRITIONEvaluation of high-protein supplementation in weight2008
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYVirologic Response to Lopivir-Ritovir2008
• JOURL OF INFECTIOUS DISEASESInitiatives for developing and comparing genotype interpretation systems2008
• Jourl of HIV therapyIntegrase inhibitors: a clinical review of raltegravir and elvitegravir.2008
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYEffect of concomitantly administered rifampin on the pharmacokinetics2007
• JOURL OF INFECTIOUS DISEASESPhase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor2007
• JOURL OF INFECTIOUS DISEASESA randomized, partially blinded phase 2 trial of antiretroviral therapy2006
• AIDS RESEARCH AND HUMAN RETROVIRUSESN88D facilitates the co2006
• JOURL OF INFECTIOUS DISEASESIncorporating drug-resistance measurements into the clinical magement of HIV-1 infection2006
• AMERICAN JOURL OF EPIDEMIOLOGYThe study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design2006
• QUALITY OF LIFE RESEARCHThe effect of diagnosis with HIV infection on health-related quality of life2006
• MedGenMed : Medscape general medicineCase files from Stanford University Medical Center2006
• CLINICAL PHARMACOLOGY & THERAPEUTICSPharmacokinetic interactions between indivir plus ritovir and calcium channel blockers2005
• JOURL OF INFECTIOUS DISEASESHIV-1 protease and reverse-transcriptase mutations2005
• CLINICAL INFECTIOUS DISEASESAntiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection2005
• CLINICAL INFECTIOUS DISEASESAccuracy, precision, and consistency of expert HIV type 1 genotype interpretation2005
• JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESDetection of minority populations of HIV2005
• INTERTIOL JOURL OF STD & AIDSPrevalence of antiretroviral drug resistance in the HIV-12004
• ANTIVIRAL THERAPYClinically validated genotype alysis: guiding principles and statistical concerns2004
• AIDSHigh levels of adherence do not prevent accumulation of HIV drug resistance mutations2003
• JOURL OF INFECTIOUS DISEASESLack of detectable human immunodeficiency virus type 1 superinfection during 1072 person2003
• AIDSExtended spectrum of HIV2003
• JOURL OF VIROLOGYMutation patterns and structural correlates in human immunodeficiency virus type 1 protease2003
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYVirtual inhibitory quotient predicts response to ritovir boosting of indivir2002
• JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESSubtle decreases in stavudine phenotypic susceptibility predict poor virologic response to2002
• ANTIMICROBIAL AGENTS AND CHEMOTHERAPYEvolution of primary protease inhibitor resistance mutations during protease inhibitor salvage2002
• JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESCharacterization of the HIV2001
• AIDS clinical careHIV drug resistance testing: an update for the clinician.2001
• JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESGenotypic correlates of a virologic response to stavudine after zidovudine monotherapy2001
• AIDSNon-adherence to highly active antiretroviral therapy predicts progression to AIDS2001
• AIDSPhenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment2001
• JOURL OF CLINICAL MICROBIOLOGYHigh degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease2001
• AIDS RESEARCH AND HUMAN RETROVIRUSESHighly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes2000
• ARCHIVES OF INTERL MEDICINEAdherence to isoniazid prophylaxis in the homeless - A randomized controlled trial2000
• AIDSAdherence to protease inhibitors, HIV-1 viral load2000
• ANTIVIRAL THERAPYThe relation between baseline HIV drug resistance and response to antiretroviral therapy2000
• JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESEfavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients2000
• ANLS OF INTERL MEDICINEHIV-1 genotypic resistance patterns predict response to saquivir1999
• CLINICAL INFECTIOUS DISEASESInvasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS1999
• Lawrence, J., Schapiro, J., Winters, M., Montoya, J., Zolopa, A., PesaClinical resistance patterns1999
• JOURL OF COMMUNITY HEALTHAssociation between time homeless and perceived health status among the homeless in San Francisco1997
• AIDSPREVALENCE OF MEASLES ANTIBODIES IN ADULTS WITH HIV-INFECTION1992

Dr. Andrew Zolopa M.D.'s Practice location